Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

30 trials with published results (13%)

Research Maturity

147 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.7%

11 terminated out of 235 trials

Success Rate

93.0%

+6.5% vs benchmark

Late-Stage Pipeline

22%

52 trials in Phase 3/4

Results Transparency

20%

30 of 147 completed with results

Key Signals

30 with results93% success11 terminated

Data Visualizations

Phase Distribution

185Total
Not Applicable (82)
Early P 1 (3)
P 1 (27)
P 2 (21)
P 3 (29)
P 4 (23)

Trial Status

Completed147
Unknown42
Recruiting16
Terminated11
Withdrawn9
Not Yet Recruiting7

Trial Success Rate

93.0%

Benchmark: 86.6%

Based on 147 completed trials

Clinical Trials (235)

Showing 20 of 20 trials
NCT07754279Phase 1CompletedPrimary

Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers

NCT05559502Not ApplicableCompletedPrimary

High Flow Nasal Oxygenation vs Endotracheal Intubation on Recovery Profiles in Laryngeal Microsurgery

NCT04125563Phase 2CompletedPrimary

Influence on Cough and Airway Symptoms by Oral Capsaicin

NCT07684586Phase 1WithdrawnPrimary

A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes

NCT07778953Not ApplicableNot Yet RecruitingPrimary

90% Effective Infusion Time of Sufentanil to Prevent Induction Cough: A Biased Coin Sequential Study

NCT07288528Phase 4Not Yet RecruitingPrimary

A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough

NCT03105843Phase 4Completed

Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol

NCT07660380Phase 4RecruitingPrimary

Oliceridine vs Sufentanil for Cough During Anesthesia Induction

NCT05600777Phase 3Active Not RecruitingPrimary

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

NCT05599191Phase 3CompletedPrimary

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

NCT06201494Recruiting

Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents

NCT06579989Not ApplicableNot Yet RecruitingPrimary

Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures

NCT05273190Not ApplicableRecruitingPrimary

Stimulation of the Larynx to Treat Unexplained Chronic Cough

NCT06190431Not ApplicableRecruitingPrimary

Does the Coaching Function Improve the Learning of Mechanical In-exsufflation (MI-E) in Paediatric Subjects?

NCT04642352RecruitingPrimary

Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough

NCT07330856Phase 4RecruitingPrimary

Evaluation of Treatments for Dry or Productive Cough

NCT03505216Recruiting

Swiss Paediatric Airway Cohort

NCT05989698Not ApplicableRecruitingPrimary

Validation of the C-mo System - Cough Monitoring

NCT07427303Not ApplicableNot Yet Recruiting

Focused Echocardiography for Primary Care Physicians

NCT06716645Phase 4Completed

A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin

Scroll to load more

Research Network

Activity Timeline